Abstract
Utilizing a multimodality approach with minimally invasive interventional techniques, a great variety of problems within the liver can be addressed including both diagnostic and therapeutic interventions. Transjugular liver biopsy (TJLB) is a diagnostic interventional option when transabdominal percutaneous biopsy may not be safely performed or when measurements of portal venous system pressure are indicated. If portal hypertension is found, and with an appropriate clinical indication, a transjugular intrahepatic portosystemic shunt (TIPS) may be a therapeutic option. Lastly, in certain patient populations, either primary or secondary liver malignancy may be treated with selective transarterial catheter directed chemoembolization or radioembolization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alderden RA, Hall MD, Hambley TW. The discovery and development of cisplatin. J Chem Educ. 2006;83:728–724.
Azoulay D, Castaing D, Dennison A, et al. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology. 1994;19:129–32.
Baum S, Pentecost MJ. Abrams’ angiography: interventional radiology. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins; 2005. p. 581–95.
Biecker E, Roth F, Heller J, et al. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis. Eur J Gastrenterol Hepatol. 2007;19:846–52.
Bloch R, Fontaine A, Borsa J, et al. CT-guided transfemoral portocaval shunt creation. Cardiovasc Intervent Radiol. 2001;24:106–10.
Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700–10.
Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol. 2001;35:421–30.
Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl. 2004;10:107–10.
Catalano OA, Singh AH, Uppot RN, et al. Vascular and biliary variants in the liver: implications for liver surgery. Radiographics. 2008;28:359–78.
Cheng BQ, Jia CQ, Liu CT, et al. Chemoembolization with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized prospective controlled trial. JAMA. 2008;299(14):1669–77.
Chung JW, Park JH, Han JK, et al. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Am J Roentgenol. 1995;165:315–21.
Cillo U, Vitale A, Brolese A, et al. Liver transplantation for hepatocellular carcinoma: need for a new patient selection strategy. Ann Surg. 2004;240(5):924–5.
Colapinto RF, Stronell RD, Gildiner M, et al. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. Am J Roentgenol. 1983;140:709–14.
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (Version 1.1). Eur J Cancer. 2009;45:228–47.
El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36(5):74–83.
Forauer AR, McLean GK. Transjugular intrahepatic portosystemic shunt constraining stent for the treatment of refractory postprocedural encephalopathy: a simple design utilizing a Palmaz stent and Wallstent. J Vasc Interv Radiol. 1998;9:443–6.
Gates J, Hartnell GG, Stuart KE, et al. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics. 1999;19(2):399–414.
Georgiades CS, Hong K, D’Angelo M, et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:1653–9.
Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127:194–205.
Grady ED. Internal radiation therapy of hepatic cancer. Dis Colon Rectum. 1979;22:371–5.
Gyves JW, Ziessman HA, Ensminger WD, et al. Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med. 1984;25:972–7.
Haskal ZJ, Cope C, Soulen MC, et al. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology. 1995;195:485–8.
Haskal ZJ, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee. J Vasc Interv Radiol. 2001;12:131–6.
Hidajat N, Tobbe H, Hosten N, et al. Transjugular intrahepatic portosystemic shunt and transjugular embolization of bleeding rectal varices in portal hypertension. Am J Roentgenol. 2002;178:362–3.
Hu HT, Kim JH, Lee LS, et al. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol. 2011;22(7):917–23.
Hung JC, Redfern MG, Mahoney DW, et al. Evaluation of macroaggregated albumin particle sizes for use in pulmonary shunt patient studies. J Am Pharm Assoc. 2000;40:46–51.
Ingold JA, Reed GB, Kaplan HS, et al. Radiation hepatitis. Am J Roentgenol. 1965;93:200–8.
Kettenbach J, Stadler A, Katzler IV, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol. 2008;31:468–76.
Kirsch B. Mitomycin-C. In: Thackery E, editor. Gale encyclopedia of cancer. Detroit: Gale Group; 2004.
LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995;108:1143–51.
Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2009;33:41–52.
Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90 yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919–24.
Liapi E, Geschwind JFH. Chemoembolization for primary and metastatic liver cancer. Cancer J. 2010;16(2):156–62.
Liu DM, Salem R, Bui JT, et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005;16:911–35.
Llovet JM, Real MI, Montana X, et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734–9.
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.
Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. New Eng J Med. 2008;359:378–90.
Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–71.
Lueng DA, Goin JE, Sickles C, et al. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12(3):321–6.
Maeda A, Houda M, Kuramochi T, et al. Doxorubicin cardiotoxicity: diastolic cardiac myocyte dysfunction as a result of impaired calcium handling in isolated cardiac myocytes. Jpn Circ J. 1998;62(7):505–11.
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New Eng J Med. 1996;334:693–9.
McDill DB, Rakela J, Zinsmeister AR, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99:1396–400.
McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol. 2007;16:3–5.
MedlinePlus. National Library of Medicine (US), Bethesda. http://www.nlm.nih.gov/medlineplus. 2011; Accessed on January 2011
Mel IM, Pack GT. Treatment of inoperable cancer of the liver by intraarterial radioactive isotopes and chemotherapy. Cancer. 1967;3J:793–8.
Middlebrook M, et al. Improved method for transjugular liver biopsy. J Vasc Interv Radiol. 1999;10:807–9.
Murthy R, Nunez R, Szklaruk J, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25:41–55.
Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553–61.
National Digestive Diseases Advisory Board. Role of transjugular intrahepatic portal systemic shunt (TIPS) in therapy of portal hypertension. Workshop, Feb 28–Mar 1, 1994, Bethesda, MD.
Nishimine K, Saxon RR, Kichikawa K, et al. Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent grafts: experimental results in swine. Radiology. 1995;196:341–7.
Nolan TR, Grady ED. Intravascular particulate radioisotope therapy: clinical observations of 76 patients with advanced cancer treated with 90-yttrium particles. Am Surg. 1969;35:181–8.
O’Neill MJ, Weissleder R, Gervais DA, et al. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. Am J Roentgenol. 2001;177:615–8.
Palma LD. Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol. 1998;71(848):808–18.
Patel NH, Haskal ZJ, Kerlan RK, editors. SCVIR syllabus: portal hypertension: diagnosis and interventions. 2nd ed. Fairfax: SCVIR; 2001.
Pieters PC, Miller WJ, DeMeo JH. Evaluation of the portal venous system: complementary roles of invasive and noninvasive imaging strategies. Radiographics. 1997;17:879–95.
Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol. 2002;13:155–61.
Riaz A, Lewandowski RJ, Kulik L, et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009;20:1121–30.
Riaz A, Kulik LM, Mulcahy MF, et al. Yttrium-90 radioembolization in the management of liver malignancies. Semin Oncol. 2010;37(2):94–101.
Richter GM, Palmaz JC, Noldge G, et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiology. 1989;36:677–82.
Roche CJ, et al. Intrahepatic pseudoaneurysm complicating transjugular biopsy of the liver. Am J Roentgenol. 2001;177:819–21.
Rosado B, Kamath PS. Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl. 2003;9:207–17.
Rosch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology. 1969;92:1112–4.
Salem R, Parikh P, Atassi B, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31:431–8.
Sangro B, Gil-Alzugaray B, Rodriguez J, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer. 2008;112:1538–46.
Sangro B, Carpanese L, Cianni R, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology. 2011;54(3):868–78.
Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology. 1994;20:46–55.
Sawyer AM, McCormick PA, Tennyson GS, et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol. 1993;17:81–5.
Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl. 2004;10:36–41.
Somberg KA, Reigler JL, LaBerge JM, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk-factors. Am J Gastroenterol. 1995;90:549–55.
Spies JB, Rosen RJ, Lebowitz AS. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology. 1988;166:381–7.
Szyszko T, Al-Nahhas A, Tait P, et al. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun. 2007;28:21–4.
Tripathi D, Therapondos G, Redhead DN, et al. Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol. 2002;14:827–32.
Tripathi D, Ferguson J, Barkell H, et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol. 2006;18:225–32.
Uflacker R. Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis. Tech Vasc Interv Radiol. 2003;6(1):59–69.
Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46:474–81.
Wallace MJ, Narvios A, Lichtiger B, et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol. 2003;14:323–7.
Wilson MW, Gordon RL, LaBerge JM, et al. Liver transplantation complicated by malpositioned transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1995;6:695–9.
Yamada R, Nakatsuka H, Nakamura K, et al. Hepatic artery embolization in 32 patients with unresectable hepatoma. Osaka City Med J. 1980;26:81–96.
Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397–401.
Yoon CJ, Chung JW, Cho BH, et al. Hepatocellular carcinoma in the caudate lobe of the liver: angiographic analysis of tumor-feeding arteries according to subsegmental location. J Vasc Interv Radiol. 2008;19:1543–50.
Young JY, Rhee TK, Atassi B, et al. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18:1375–82.
Zizka J, Elias P, Krajina A, et al. Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients. Am J Roentgenol. 2000;175:141–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Patel, I., Pirasteh, A., Prologo, J.D. (2013). Liver Intervention: Angiography. In: Hamm, B., Ros, P.R. (eds) Abdominal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13327-5_226
Download citation
DOI: https://doi.org/10.1007/978-3-642-13327-5_226
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-13326-8
Online ISBN: 978-3-642-13327-5
eBook Packages: MedicineReference Module Medicine